Swedish Physical Activity and Fitness Longitudinal Study
NCT ID: NCT06496204
Last Updated: 2025-04-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
429 participants
OBSERVATIONAL
2021-03-22
2022-06-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physical Activity as Intervention Against Age-related Loss of Muscle Mass and Function
NCT02123641
Resistance and/or Endurance Training, What is Most Effective in Prevention of Cardiovascular Diseases?
NCT00986024
Physical Activity Program for Counteracting Sarcopenia
NCT04172285
Muscle Aging Evaluation
NCT06845748
Improving Muscle Strength, Mass and Physical Function in Older Adults
NCT03297632
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The questionnaire also included questions about health, disease, medication, and personal traits. Testing of physical performance: Some tests for physical performance were used at all data collections from 16 to 63 years, including aerobic capacity and muscle static and dynamic strength. Specific tests assessing muscle function in relation to muscle weakness were added to the testing at 63 years. Venous blood was drawn for analysis of standard health variables as well as extended studying of endocrine profile and inflammatory cell profile. The muscle size of two selected muscles on the leg were estimated by ultrasound. Body composition and muscle size were determined in 60 subjects by MR imaging of the whole body. Testing of neurological status: Motor nerve conductions studies (NCS) were performed on the right median and ulnar, and bilaterally on tibial, and peroneal nerves. Sensory NCS were performed on the right median, ulnar, and superficial radial nerves, and bilaterally on the sural and superficial peroneal nerves. Motor and sensory conduction velocities, proximal and distal compound muscle action potentials (CMAP), and sensory nerve action potentials (SNAP) were recorded. For motor unit number estimation (MUNE) m. tibialis anterior (TA) and m. abductor policies brevis (ABP) were tested by electrical stimulation of the median and peroneal nerve, respectively. MUNE was obtained by dividing the size of the maximal CMAP by the size of the mean surface-recorded single motor unit potential (S-MUP). MUNE=Max CMAP (area) / Mean SMUP (area). To define small fibre neuropathy a skin biopsy was collected to measure the density of small fibre epidermal innervation. Skeletal muscle samples were obtained with a Bergström biopsy needle from m. vastus lateralis and were snap-frozen in liquid nitrogen cooled isopentane and stored at -80°C. To maximize the possibility to include high number of neuromuscular transmission junctions (endplates) in the muscle biopsy, the optimal biopsy site was determined by location of maximal twitch response to electrical nerve stimulation. Furthermore, the needle was re-directed after penetration of the skin to cut myofibers as longitudinally as possible. This approach was chosen to optimize the conditions for analyses of the NMJ.
ANALYSES OF SKELETAL MUSCLE: The data collection at 63 years will be completed with morphological and immune-/enzyme-histochemical analysis of 120 muscle biopsies. Disruption of axon and motor unit integrity may initiate and drive the wasting and functional impairment of skeletal muscles during aging. To test our hypothesis of the neurogenic impact on loss of muscle strength, the investigators will examine and compare biopsies of skeletal muscle from age 27 and 63 in the same individuals. This part of the analyses will focus on fibre type transitions (myosin subtypes), change in fibre-size and clustering of fibre types with advancing age (a sign of denervation followed by re-innervation). For the biopsies at age 63, after cryo-sectioning, muscle sections will be stained using enzyme histochemistry, histological stains, and immunohistochemistry, followed by confocal microscopy imaging. From 27 years of age there are sectioned and stained muscle tissue available from a subgroup of the cohort, to compare with the characteristics of the muscle at 63 years. These samples need to be digitalised in our microscopy and imaging analysis facility before analyses of fibre clustering. Also, the muscle biopsies harvested at age 63 will be analysed for NMJ by staining for acetylcholine (presynaptic), CHARNs (postsynaptic receptors), terminal Schwann cells, and the parallel autonomic innervation (norepinephrine). The investigators will use a panel of antibodies including markers of axonal and terminal Schwann cell involvement in re-innervation. The cryo-sectioning and refinement/validation of the labelling protocols will be performed by HR in collaboration with BU, TG and MW. HR has a full-time position in the group and is specialized in these methods. In addition, the investigators apply for funding 1 month for a research assistant to digitalise and analyse muscle fibre composition from age 27. ANALYSES OF MAGNETIC RESONANCE IMAGES Subjects have been scanned with a 1.5 Tesla Siemens camera at Karolinska University Hospital in Huddinge. The investigators used a modified 2-point Dixon fat-water sequence that scans the entire body in 6 minutes. Automatic image analysis will be performed using AMRA™ segmentation software (Advanced MR Analytics AB, Linköping, Sweden). The data provided include adipose and muscle tissue of the entire body (from neck to knee), muscle volume and muscle fat infiltration in the anterior and posterior thigh muscles, and subcutaneous adipose tissue in the abdomen and fat content of the liver. The advantage of the results of the MRI technique is not only the very high reproducibility, but also the fact that it can be adjusted to body size using muscle-specific z-scores for volume and fat infiltration. This has been a major problem in the past, as essentially small people were much more easily classified as sarcopenic, while overweight/obese people were rarely classified as having too little muscle mass. The standardized z-score has been calculated for different age groups based on over 10 000 people scanned in the UK Biobank. Both muscle volume value and fat infiltration of muscle were associated with physical function, with the strongest predictive value when low muscle volume was combined with high fat infiltration, i.e. adverse muscle composition.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SPAF
At the beginning of the study, in 1974, a group of 429 (224 males, and 205 females) of pupils at secondary high school in Sweden was systematically selected: The country was stratified into six regions with a similar population size and climate. In each region, one or more secondary high schools were randomly selected. At each school, the number of pupils was selected in proportion to the distribution of girls and boys in secondary high school, the number of pupils in the region, and the proportion of pupils in each school program (theoretical three-year program to prepare for higher studies or practical two-year program to prepare for working life). Individual subjects were then randomly selected at each school based on these criteria and are representative of 16-year-old girls and boys attending secondary high school in Sweden.
All participants have been invited to followups at age 34, 52 and 63 years
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Swedish Research Council for Sport Science
OTHER
The Swedish Research Council
OTHER_GOV
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maria Westerstahl
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Karolinska institutet
Stockholm, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DNR 4-397/2021
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
DNR 4-2537/2023
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
P2023-0054
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
P2024-0076
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
SPAF: dnr 2020-04338 SERA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.